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Can interventions that aim to decrease 
Lyme disease hazard at non-domestic sites 
be effective without negatively affecting 
ecosystem health? A systematic review protocol
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Abstract 
Background: Lyme disease (LD) is the most commonly reported, broadly distributed vector-borne disease of the 
northern temperate zone. It is transmitted by ticks and, if untreated, can cause skin, cardiac, nervous system and mus-
culoskeletal disease. The distribution and incidence of LD is increasing across much of North America and Western 
Europe. Interventions to decrease exposure to LD hazard by encouraging behavioural change have low acceptance 
in high risk groups, and a safe, effective human LD vaccine is not presently available. As a result, habitat level interven-
tions to decrease LD hazard itself (i.e. levels of infected ticks) have been proposed. However, some interventions may 
potentially negatively affect ecosystem health, and consequentially be neither desirable, nor politically feasible. This 
systematic review will catalogue interventions that aim to reduce LD hazard at non-domestic sites, and examine the 
evidence supporting those which are unlikely to negatively affect ecosystem health.
Methods: The review will be carried out in two steps. First, a screening and cataloguing stage will be conducted to 
identify and characterise interventions to decrease LD hazard at non-domestic sites. Secondly, the subset of inter-
ventions identified during cataloguing as unlikely to negatively affect ecosystem health will be investigated. In the 
screening and cataloguing step literature will be collected through database searching using pre-chosen search 
strings, hand-searching key journals and reviewing the websites of public health bodies. Further references will be 
identified by contacting stakeholders and researchers. Article screening and assessment of the likely effects of inter-
ventions on ecosystem health will be carried out independently by two reviewers. A third reviewer will be consulted 
if disagreements arise. The cataloguing step results will be presented in tables. Study quality will then be assessed 
independently by two reviewers, using adapted versions of established tools developed in healthcare research. These 
results will be presented in a narrative synthesis alongside tables. Though a full meta-analysis is not expected to be 
possible, if sub-groups of studies are sufficiently similar to compare, a partial meta-analysis will be carried out.
Keywords: Borreliosis, Evidence synthesis, Control measures, One health, Vector-borne, Ticks, Ixodes, Medical 
acarology, Integrated pest management, Zoonoses
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Background
Transmitted by blood-feeding ticks, Lyme disease (LD) is 
the most common vector-borne disease of the temperate 
northern hemisphere and is caused by a bacterial infec-
tion of Borrelia burgdorferi s.l. (Bb) [1]. Initial symptoms 
of LD can be relatively mild, and the early prescription of 
antibiotics is effective at reducing its severity [2]. How-
ever, if untreated, LD can progress to serious systemic 
disease, involving skin, cardiac, nervous system, and 
musculoskeletal damage [3]. Though physician records 
resembling LD date back to the nineteenth century, it 
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was not until the 1970s that LD per se was described and 
Ixodes ticks identified as vectors [4].
Annual incidence is estimated at 106.6 per 100,000 per-
sons in the USA [5], with the great majority of cases aris-
ing in northeastern and northern midwestern states [4]. 
Similarly whilst incidence across Western Europe is esti-
mated at 56.03 per 100,000 people, it differs significantly 
between countries, ranging from 0.001 per 100,000 (Italy) 
to 464 per 100,000 (Sweden) [6]. In Europe, as in the USA 
[7, 8], the geographic spread and reported number of clin-
ical cases is rising in many areas [9–11]. In some countries 
the increase in reported cases may partly be explained 
by growing awareness amongst clinicians and the public 
about disease symptoms and transmission routes [12]. 
However, there is also strong evidence ecological and 
social determinants are driving increased incidence. Eco-
logical factors that have been associated with rising LD 
hazard include reafforestation, habitat fragmentation, 
changes in vector distribution and abundance, and shifts 
in the community composition and population dynam-
ics of predators and tick hosts [13]. Disease risk is fur-
ther shaped by social practices which can increase human 
exposure to LD hazard, such as outdoor recreational pur-
suits, and the construction of housing within forest matri-
ces [13]. The relative contribution of many of these factors 
to LD emergence remains contested, but is likely to differ 
between and within countries [14], partly explaining the 
geographical disparity in incidence rates and patterns of 
disease risk across the northern temperate zone. Reported 
cases are likely to be an underestimate of actual LD preva-
lence. For example, tests of Scottish blood donor supplies 
found 4.2 % (60/1440) were seropositive for Bb whilst the 
Scottish (laboratory confirmed) incidence rate is reported 
at 9.82 cases per 100,000 persons [15]. This, alongside 
similar screening of occupationally high risk groups [16, 
17], suggests many people are bitten by Bb infected ticks, 
but either do not develop LD or receive a diagnosis.
Vaccination and encouraging precautionary behav-
iour change have had only limited success with LD and in 
some cases faced outright opposition. A human LD vac-
cine licensed in the USA in 1998 was withdrawn by its pro-
ducer 3  years later following sales drops amidst a health 
scare catalysed by anti-vaccine groups [18]. New vaccines 
in development could have greater commercial viability as 
they are designed to target multiple Borrelia or tick vec-
tors, and thus work across larger geographic areas [19–21]. 
Nevertheless, they are still likely to face major barriers to 
widespread adoption [22]. Recommended precaution-
ary behaviours designed to decrease the risk of being bit-
ten by infected ticks include wearing light coloured clothes 
with long sleeves and trousers tucked into socks, the use 
of insecticide on skin and clothing, sticking to paths and 
avoiding walking through long grass [23, 24]. Despite 
considerable effort to popularise them, many of these 
measures remain largely un-adopted. One recurring theme 
in interviews with UK park visitors was resistance to view-
ing the countryside as a place that included risk, in part 
because it clashed with framing of visits to such places as 
restorative. This led some interviewees to oppose on-site 
signage and leaflets, whilst the common advice to wear long 
sleeves and trousers was rejected as it would reduce their 
enjoyment of summer [25]. Even amongst those who had 
previously suffered LD, during-visit precautionary meas-
ures remained unpopular [26]. Similar findings have been 
reported from the Netherlands [27], the USA [28], Switzer-
land and Canada [29]. Even when adopted, most personal 
preventative measures are not highly effective [30–32]. 
Whilst some innovations promise greater risk reduction, 
especially those relating to acaracide treated clothes [33], 
basic social barriers to engagement remain. For instance, in 
recent work by Mowbray et al. [34] respondents stated they 
would not follow advice to tuck trousers into socks. A com-
mon explanation for why: ‘Because I’d look stupid’.
Following a case-controlled evaluation, Vázquez et  al. 
[32] concluded educational work to encourage personal 
preventative measures should continue, but given its lim-
ited success so far and the unavailability of a vaccine, hab-
itat level interventions to decrease LD hazard should be 
developed in areas of high tick-human contact. Unfortu-
nately, some suggested tactics may negatively affect eco-
system health. For example, acaracide spraying to control 
LD may potentially impact non-target species [35], as 
happened across multiple trophic levels with DDT [36], 
which was sprayed by air over much of the Soviet Union 
as a control strategy for Tick-borne encephalitis [31]. A 
reduction of LD hazard may potentially be made possi-
ble by eradicating the animals and birds that act either as 
reservoirs of the Bb pathogen, or as hosts supporting tick 
vector populations through blood-meal provision (for 
example deer [37]). Eradications may seem justified from 
a narrow pathogen-focused perspective, but community 
disassembly may have significant effects on ecosystem 
function, especially where the disease system involves a 
diverse range of species. As areas with high tick-human 
contact are often managed for both recreation and biodi-
versity such actions may neither be desirable nor politi-
cally feasible [29, 38]. More broadly there is active debate 
within Public Health about the ethics involved in wide-
spread culling of wildlife as a disease control strategy 
[39]. With such issues in mind, and given the continuing 
emergence of LD across the northern temperate zone, an 
evidence synthesis of interventions which are unlikely to 
negatively affect ecosystem health is much needed.
This systematic review will catalogue interventions to 
decrease LD hazard at non-domestic sites, and evaluate the 
evidence supporting those assessed as unlikely to negatively 
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affect ecosystem health. Such interventions range from 
those presumed to have a generally neutral effect on eco-
systems (acaracide application to wild or domesticated ani-
mals, [40, 41] and vaccines for reservoir hosts [42]), to ones 
which may have win–win outcomes for public health and 
conservation (local deer exclusion or reduction [43], preda-
tor reintroduction [44–46], decreasing forest fragmentation 
[47], removal of invasive trees as part of habitat restoration 
[48] and woodland biodiversity management [49]).
Objective of the review
The systematic review’s objective is to catalogue inter-
ventions to decrease LD hazard at non-domestic sites, 
and assess the evidence for effectiveness of a subset iden-
tified as unlikely to negatively affect ecosystem health. A 
scoping search found no published or prospectively reg-
istered systematic reviews with the same topic. Domes-
tic measures (such as gravel barriers separating garden 
lawns from woodland ecotones) may reduce hazard 
where residential exposure is of high concern [50]. How-
ever, the focus of this review will be on interventions 
which could be carried out at non-domestic sites, such 
as Country Parks, where the greatest number of peo-
ple exposed to LD hazard are recreational visitors. Such 
sites differ in size within and between countries, but for 
illustration UK accredited Country Parks range from a 
minimum of 10 hectares [51] to over 1000 [52]. In larger 
Parks, such as National Parks, visitors often concentrate 
at a small numbers of key locations [53, 54] within this 
spatial range, where interventions to reduce LD hazard 
could potentially be incorporated into existing site man-
agement plans [55]. The project’s target audience is: (a) 
land managers such as local authorities and conservation 
organisations; and (b) scientists and public health bodies 
involved in research around LD and tick-borne diseases.
The screening and cataloguing step will identify inter-
ventions and asses their likely effects on ecosystem 
health. The systematic review will then analyse the sub-
set of interventions identified as unlikely to negatively 
affect ecosystem health to answer the review’s primary 
research question: which interventions to decrease Lyme 
disease hazard at non-domestic sites are unlikely to neg-
atively affect ecosystem health and what evidence exists 
to support their effectiveness?
Components of the primary research question
Population
Non-domestic sites (i.e. lands not adjoining and belong-
ing to a house) with LD hazard (i.e. Bb infected ticks of 
one or more species known to feed on human blood). 
The geographical scope of the review will be global, but is 
likely to reflect the predominantly northern hemispheric 
distribution of Bb.
Intervention
Any intervention to reduce site LD hazard, that is 
assessed as unlikely to negatively affect ecosystem health 
(as defined in the “Data synthesis and presentation” 
section).
Comparator
No intervention or an alternative intervention.
Outcomes
Spatial and/or temporal distribution and abundance of 
site LD hazard. It is expected studies will have quantified 
this differently.
Methods
The systematic review will be carried out in two steps. 
First, a screening and cataloguing step will identify 
and characterise interventions to decrease LD haz-
ard at non-domestic sites. This will include identify-
ing subsets of interventions that, (i) would be unlikely 
to negatively affect ecosystem health, or (ii) would 
be likely to negatively affect ecosystem health. Sub-
sequently, the subset of interventions identified as 
unlikely to negatively affect ecosystem health will be 
investigated, and their effectiveness at reducing LD 
hazard determined.
Prospective registration of review
As the review topic bridges public health and environ-
mental management, it is registered with both the Col-
laboration for Environmental Evidence and PROSPERO, 
the international database of prospectively registered 
systematic reviews in health and social care (Unique ID 
CRD42016046629) [56].
Searches
The flowchart in Fig.  1 illustrates the systematic review 
pathway. Articles will be collected primarily through 
database searching with other literature suggested by 
stakeholders and researchers in the field.
Search terms and languages
Table 1 shows search terms and search strings to be used. 
Searches will be conducted in English, which is a limita-
tion of the systematic review.
Search strings and/or combinations of searches
Listed in Table 1.
Estimating the comprehensiveness of the search
A list of relevant papers (see Additional file  1) 
was used to develop search strings and test search 
comprehensiveness.
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Citations 
identified 
through 
database 
searching
(n =   )
Citations 
identified 
‘hand 
searching’
key journals
(n =   )   
On-line 
material from 
public health 
agencies 
(n =   )
Other: existing author 
library (n =   ) 
from contacted 
researchers (n =   )
from included articles 
(n =   )
Citations and material after 
duplicates removal (n =  ) 
Screening of  titles/abstracts
for interventions to decrease
non-domestic LD hazard (n =  )
Excluded (n =  )*
Screening of  full articles (n =  )
Assessment of full articles
to identify intervention sub-sets 
(likely or unlikely to negatively affect 
ecosystem health) (n =  )
Excluded (n =  )*
No interventions to 
decrease  non-domestic 
LD hazard (n =   )
Study duplication (n =  )
noitacifitnedI
gnineercS
Table: Which proposed 
interventions to decrease 
Lyme disease hazard at non-
domestic sites are likely to 
negatively affect ecosystem 
health?
I
fo
noitacifitned
su
b-
se
ts
Likely to negavely affect 
ecosystem health (n =  )**
Unlikely to negavely affect 
ecosystem health (n =  )**
Table: Which proposed 
interventions to decrease 
Lyme disease hazard at non-
domestic sites are unlikely to 
negatively affect ecosystem 
health?
Studies quality assessed (n =   )***
dedulcnI
Studies included in narrative 
synthesis and primary research 
question table (n =   )
No overall meta-analysis expected to be possible. If sub-groups of studies are sufficiently 
similar to compare a partial meta-analysis of the data will be carried out.  
Excluded due to quality
(n =  )* Reasons = 
Fig. 1 LD intervention systematic review flow diagram. Outputs in grey boxes. Appendix to the report will include *spreadsheets with all excluded 
references, **assessment forms for each intervention, and ***quality assessment forms for each included study. Flow diagram adapted from PRISMA 
2009 [63]
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Publication databases to be searched
Articles indexed in MEDLINE will be searched via Pub-
Med using US National Library of Medicine controlled 
Medical Subject Headings (MeSH) selected using the 
PubMed Search Builder. Table  1 shows databases to be 
used. Literature will be limited to that published from 
1983 onwards, the year in which Bb was identified as the 
causative agent of LD [4].
The contents of the following key journals will be exam-
ined at title level for any articles related to LD: Ecohealth, 
Medical and Veterinary Entomology, Parasites and Vec-
tors, Tick and Tick-borne Diseases, Experimental and 
Applied Acarology, Trends in Parasitology. For practical 
reasons, hand searching will be restricted to journal vol-
umes between 1/1/2010 and the time of search. Collected 
references will be subject to exclusions as per Fig. 1.
Internet searches to be conducted
None.
Specialist searches—searches for grey literature
Websites of the following organisations will be reviewed 
for public health advice, grey literature and details of 
unpublished or ongoing studies: Public Health England 
(UK), Health Protection Surveillance Centre (Ireland), 
European Centre for Disease Prevention and Control 
(EU), Centers for Disease Control and Prevention (USA), 
Public Health Agency (Canada), World Health Organi-
sation (global). Where appropriate, these bodies will be 
contacted for further information.
Supplementary searches such as Bibliographical searches 
and literature provided directly by stakeholders
The reference lists of included articles will be scanned 
for relevant citations. Once searching and exclusions are 
completed, a list of included articles will be sent to estab-
lished researchers in the field along with this protocol 
and a request for additional recommendations, includ-
ing grey literature and unpublished studies. This protocol 
will be promoted on the University of Brighton website 
and advertised via social media (Twitter and Research 
Gate) to engage wider stakeholders and the research 
community. Those submitting suggestions will be offered 
listing in acknowledgements. References from a pre-
existing library of the authors along with suggestions by 
others will be screened for duplication and eligibility as 
outlined below and illustrated in Fig. 1.
Article screening and study inclusion criteria
Screening
Screening will be carried out independently by two 
reviewers with spreadsheets for each set of inclusions 
and exclusions available as supplementary files. Identi-
fied references will be screened for eligibility first using 
titles, then abstracts and finally by full texts. In line with 
Collaboration for Environmental Evidence guidance [57], 
at the beginning of the title, abstract and full text screen-
ing stages a Kappa analysis using a random sample of 200 
articles will be carried out to assess consistency between 
the reviewers in applying the inclusion and exclusion 
criteria. Selection criteria will be further developed and 
retested if the obtained Kappa rating is not 0.6 or more. 
Where there is a disagreement between reviewers on 
inclusion at full text stage a third independent reviewer 
will be consulted.
Inclusion criteria
Literature will be accepted for inclusion when the pop-
ulation involved is a non-domestic site with LD hazard, 
an intervention is proposed to reduce LD hazard (inter-
vention categories listed below, in the “Relevant inter-
ventions” subsection) and the outcome measured is LD 
hazard (preferred outcome metric detailed in the “Rel-
evant outcomes” subsection). Non-English language arti-
cles with English language abstracts that pass abstract 
level screening, will be translated and assessed for inclu-
sion at full article stage when abstracts state the article 
is a report of an intervention study to reduce LD hazard. 
When not they will be listed in the appendix. The scoping 
search indicated some proposals are not backed by stud-
ies with reliable comparator data. This will be indicated 
following study quality assessment in the evidence syn-
thesis step but presence of a valid comparator will not be 
a requirement for inclusion in the review. Similarly type 
of study design will not determine inclusion but will be 
considered during quality assessment.
Relevant subject(s) Any non-domestic sites with LD haz-
ard worldwide.
Relevant intervention(s) Interventions proposed to 
reduce LD hazard, including those altering Bb and tick vec-
tor host community composition, vector populations, Bb 
Table 1 Search terms and search strings
Databases Search terms and strings
PubMed “Lyme disease/prevention and control” [Mesh] 
OR “Borrelia infections/prevention and control” 
[Mesh]
Web of science
Embase
Global health
Scopus
Cochrane library
(Intervention* OR control* OR “one health” OR 
decreas* OR reduc* OR limit* OR prevent* OR 
affect* OR effect* OR lower* OR alter* OR elimi-
nat*) AND (Lyme disease OR Lyme borreliosis OR 
tick-borne) AND (Borrelia OR Ixodes OR tick* OR 
vector* OR hazard* OR risk*)
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prevalence within vectors, site landscaping, plant commu-
nity composition, and habitat structure and connectivity.
Relevant comparator(s) No intervention or an alterna-
tive intervention.
Relevant outcomes Site LD hazard. It is expected articles 
will quantify this differently, though density of infected 
nymphs (DIN) is most appropriate [58].
Relevant types of study design Any exclusions will be car-
ried out stepwise as per Fig. 1, a filled-in copy of which will 
be included in the report. References that do not include 
interventions to decrease non-domestic LD hazard will be 
excluded at title, abstract and full text stages. All articles 
excluded at full text at any stage in the review will be listed 
in appendix with reasons given for their exclusion.
Study quality assessment
Study quality will be assessed using the Environmen-
tal-Risk of Bias Tool and the Environmental-GRADE 
Tool, adapted versions of established tools developed in 
healthcare research [59]. The Environmental-Risk of Bias 
Tool will be used to assess the risks of bias associated 
with each study, for example selection bias due to inad-
equate randomisation, and reporting bias due to selective 
reporting. The Environmental-GRADE Tool will be used 
to assess the quality of the underlying methodologies, 
ranging from randomised controlled trials (high quality), 
to case studies (low quality). Assessments will be carried 
out separately by two reviewers who will discuss grading 
differences with the intention of reaching consensus. In 
addition, the precision of effect estimates will be evalu-
ated in consultation with statistical expertise. The results 
will be included in a table in the report.
Data extraction strategy
Data extraction will be carried out by one reviewer and 
forms will be used to capture the following study data 
when available: full reference, type of study, location, 
period, habitat, vector species, pathogen species, inter-
vention, other reasons for heterogeneity (see below), 
methodology, sources of bias, LD hazard outcomes with 
mean, standard deviation and p-values, author stated key 
findings and recommendations for future work. A second 
reviewer will check the data extracted. The two review-
ers will discuss any disagreements with the intention of 
reaching consensus. If consensus is not achieved a deci-
sion on the data to be included will be taken by a third 
reviewer. Where data is missing, attempts will be made 
to contact the authors, when practicable. All completed 
data extraction forms will be included in an appendix to 
the report.
Potential effect modifiers and reasons for heterogeneity
The following list is not exhaustive, but includes potential 
effect modifiers and reasons for heterogeneity which will 
be recorded where available.
  • Outcome measure
  • time between intervention and outcome measure
  • sampling method
  • habitat type
  • vector and pathogen species
  • vector and pathogen host community composition
  • intervention type
  • climate
Data synthesis and presentation
Identification of intervention sub‑sets
Two reviewers will independently asses the included full 
articles to determine whether mentioned interventions 
would be likely or unlikely to negatively affect ecosystem 
health. Where there is a disagreement between review-
ers a third independent reviewer will be consulted. The 
meaning of the concept of ecosystem health has long 
been contested [60]. For this review, the following sum-
mary outline will be used: ‘healthy ecosystems retain vig-
our (productivity), resilience (capacity to recover from 
disturbance, indeed self-renewal), and their organization 
(e.g., biodiversity and symbiotic relations between spe-
cies)’ [61]. By this definition anthropogenic change has 
degraded many or most ecosystems in which humans are 
at risk of contracting LD. Never the less, it is anticipated 
that some interventions may further negatively affect 
ecosystem health. Forms will be developed for this step 
with pre-chosen evaluation criteria to judge the likely 
effect of interventions on: (i) vigour (measured as activity, 
metabolism or primary productivity), (ii) ecosystem resil-
ience (measured in terms of a system’s capacity to main-
tain structure and function in the presence of stress), and 
(iii) organisation (assessed as diversity and number of 
interactions between system components). See Rapport 
et al. [62] for further elaboration and examples of ecosys-
tem health assessments. All forms will be available as an 
appendix to the report.
The cataloguing section of the report will include two 
tables. One will list those interventions assessed as likely 
to negatively affect ecosystem health. It will include a 
brief description of each intervention, a list of citations 
where it was proposed or trialled (full details in Addi-
tional file 1), and a justification of the assessment. A sec-
ond table will list those interventions assessed as unlikely 
to negatively affect ecosystem health, and will likewise 
include a brief description, a justification of assessment, 
and a list of citations. In both tables justifications will ref-
erence evidence regarding the effect of interventions on 
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ecosystem health, where such evidence exists. Where it 
does not, justifications of assessments of likelihood will 
cite examples of the effects of similar interventions.
Systematic review
The systematic review will investigate the subset of 
interventions that would be unlikely to negatively affect 
ecosystem health, and determine their effectiveness at 
reducing LD hazard. As illustrated in Fig.  1, eligible lit-
erature will be assessed for study quality. The results will 
be presented in narrative, alongside tables. Given the 
considerable heterogeneities across studies indicated by 
the scoping search a full meta-analysis is not expected to 
be possible. However, if sub-groups of studies are suffi-
ciently similar to enable comparison a partial meta-anal-
ysis of the data will be carried out. A table will show the 
data on supporting evidence for each of the interventions 
that were assessed as unlikely to negatively affect eco-
system health. It will include for each study involved the 
habitat, study type, outcome statistics and study quality 
grading. This table and the associated narrative synthesis 
will answer the primary research question: which inter-
ventions to decrease Lyme disease hazard at non-domes-
tic sites are unlikely to negatively affect ecosystem health 
and what evidence exists to support their effectiveness?
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